Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax) - Concepedia

Concepedia

Publication | Open Access

Potent and selective small-molecule MCL-1 inhibitors demonstrate on-target cancer cell killing activity as single agents and in combination with ABT-263 (navitoclax)

DOI Full Paper Access

427

Citations

63

References

2015

Year

H Zhang, J Chen, Sajid Khan Tahir, Darren C. Phillips, John Xue, Paul Nimmer, Sha Jin, Morey L. Smith, Yu Xiao, Peter Kovar,

Cell Death and Disease

References

	Year	Citations

Page 1